Lifecore Biomedical, Inc. (LFCR)
NASDAQ: LFCR · Real-Time Price · USD
6.55
+0.01 (0.23%)
Oct 2, 2026, 11:52 AM EDT - Market open

Lifecore Biomedical Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Dec '25 May '25 May '24 May '23 May '22
248306249172241291
Market Cap Growth
-10.01%23.18%44.93%-28.69%-17.27%-17.12%
Enterprise Value
374472419305395424
Last Close Price
6.538.186.725.627.949.87

Price Ratios

Fiscal Year
CurrentFY 2025FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Dec '25 May '25 May '24 May '23 May '22
PE Ratio
---14.29--
Forward PE
-8.178.1725.55167.00250.59
PS Ratio
1.912.371.931.342.332.62
PB Ratio
7.269.005.253.196.863.31
P/TBV Ratio
-----4.17
P/FCF Ratio
39.6849.20----
P/OCF Ratio
19.6724.39-667.99--
PEG Ratio
-25.0625.0625.0625.0625.06

EV Ratios

Fiscal Year
CurrentFY 2025FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Dec '25 May '25 May '24 May '23 May '22
EV/Sales Ratio
2.883.653.252.373.823.81
EV/EBITDA Ratio
45.3157.32-123.49-29.82
EV/FCF Ratio
59.9475.84----

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Dec '25 May '25 May '24 May '23 May '22
Debt / Equity Ratio
4.224.222.762.393.211.71
Debt / EBITDA Ratio
16.8316.83-43.34-9.63
Debt / FCF Ratio
23.0723.07----
Net Debt / Equity Ratio
3.713.712.582.232.671.70
Net Debt / EBITDA Ratio
15.3215.32-30.8048.73-13.2810.49
Net Debt / FCF Ratio
20.2720.27-9.00-6.62-2.40-2.84
Asset Turnover
--0.520.510.390.29
Inventory Turnover
--2.452.141.961.46
Quick Ratio
2.182.181.461.021.230.22
Current Ratio
3.493.492.842.092.390.66
Return on Equity (ROE)
---76.41%20.97%-104.52%-10.65%
Return on Assets (ROA)
---3.04%-1.35%-4.67%-0.55%
Return on Invested Capital (ROIC)
-0.76%-0.76%-6.98%-3.56%-10.79%-1.05%
Return on Capital Employed (ROCE)
-0.60%-0.60%-5.70%-2.60%-9.20%-3.50%

Yields

Fiscal Year
CurrentFY 2025FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Dec '25 May '25 May '24 May '23 May '22
Earnings Yield
-13.96%-10.05%-15.56%7.00%-41.36%-40.11%
FCF Yield
2.52%2.03%-5.47%-10.56%-16.17%-18.05%
Buyback Yield / Dilution
-1.63%-7.33%5.02%-22.36%-1.67%-0.59%
SEC Filings: 10-K · 10-Q